Zobrazeno 1 - 10
of 853
pro vyhledávání: '"G Flandrin"'
Autor:
M. T. Daniel, G. Flandrin
Publikováno v:
Scandinavian Journal of Haematology. 12:23-31
β-glucuronidase activity was estimated semi-quantitatively by a cytochemical method. Strong granular enzyme activity was found to be present in lymphocytes of healthy controls with a pleiomorphic pattern of positivity. In 18 out of 20 patients with
Publikováno v:
ITBM-RBM. 25:264-268
Autor:
Nicole Dastugue, Odile Fenneteau, Eliane Duchayne, Christine Arnoulet, Danielle Sainty, Marie-Pierre Pages, Richard Garand, G. Flandrin
Publikováno v:
Leukemia & Lymphoma. 44:49-58
Since the WHO classification of haematological malignancies recommended the description of global entities, we performed a national M7-AML study to correlate morphological, immunological and cytogenetic features, and to find new clinically relevant M
Autor:
Nancy L. Harris, Clara D. Bloomfield, Jacques Diebold, James W. Vardiman, Hans Konrad Müller-Hermelink, Elaine S. Jaffe, G. Flandrin, T. A. Lister
Publikováno v:
Modern Pathology. 13:193-207
Since 1995, the European Association of Pathologists and the Society for Hematopathology have been developing a new World Health Organization (WHO) classification of hematologic malignancies. The classification includes lymphoid, myeloid, histiocytic
Autor:
Jacques Diebold, Elaine S. Jaffe, James W. Vardiman, Nancy L. Harris, Clara D. Bloomfield, Hans Konrad Müller-Hermelink, T. A. Lister, G. Flandrin
Publikováno v:
Histopathology. 36:69-86
Introduction Since 1995, the European Association of Pathologists (EAHP) and the Society for Hematopathology (SH) have been developing a new World Health Organization (WHO) classification of haematological malignancies. The classification includes ly
Autor:
Elaine S. Jaffe, Nancy L. Harris, Hans Konrad Müller-Hermelink, Jacques Diebold, James W. Vardiman, G. Flandrin
Publikováno v:
Annals of Oncology. 11:S3-S10
Background: Controversy in lymphoma classification dates back to the first attempts to formulate such classifications. Over the years, much of this controversy arose from the assumption that there had to be a single guiding principle a gold standard'
Autor:
T. A. Lister, Nancy L. Harris, Elaine S. Jaffe, G. Flandrin, Clara D. Bloomfield, Hans Konrad Müller-Hermelink, Jacques Diebold, James W. Vardiman
Publikováno v:
The Hematology Journal. 1:53-66
Introduction Since 1995, the European Association of Pathologists and the Society for Hematopathology have been developing a new World Health Organization (WHO) classification of hematologic malignancies. The classification includes lymphoid, myeloid
Autor:
Hans Konrad Müller-Hermelink, Clara D. Bloomfield, Elaine S. Jaffe, G. Flandrin, Jacques Diebold, James W. Vardiman, T. A. Lister, Nancy L. Harris
Publikováno v:
Annals of Oncology. 10:1419-1432
Summary Introduction Since 1995, the European Association of Pathologists (EAHP) and the Society for Hematopathology (SH) have been developing a new World Health Organization (WHO) Classification of hematologic malignancies. The classification includ
Autor:
Jacques Diebold, James W. Vardiman, Clara D. Bloomfield, Elaine S. Jaffe, G. Flandrin, T. Andrew Lister, Nancy L. Harris, H. Konrad Muller-Hermelink
Publikováno v:
Journal of Clinical Oncology. 17:3835-3849
PURPOSE: The European Association of Hematopathologists and the Society for Hematopathology have developed a new World Health Organization (WHO) classification of hematologic malignancies, including lymphoid, myeloid, histiocytic, and mast cell neopl